PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Comparative study between bone marrow mononuclear fraction and mesenchymal stem cells treatment in sensorimotor recovery after focal cortical ablation in rats.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23237581 ↗2012Reported benefit

Comparative study between bone marrow mononuclear fraction and mesenchymal stem cells treatment in sensorimotor recovery after focal cortical ablation in rats.

RatTBIUnspecifiedWistarMalen = MSCs n=8, BMMCs n=9, vehicle control n=18, plus 4 additiona…Intravenous, via the left jugular vein24 hours after ablation

Model: Focal cortical ablation by aspiration of all six cortical layers of the left frontoparietal cortex (+2 to -6 mm anteroposterior from bregma) under ketamine 90 mg/kg and xylazine 10 mg/kg intraperitoneal anaesthesia, with a collagen haemostatic sponge placed in the lesion

Both MSCs and BMMCs produced significant sensorimotor recovery relative to vehicle controls in the cylinder test and, from post-ablation day 35 onwards, in the adhesive removal test. The two cell types were broadly equivalent, except at day 91 when BMMC-induced recovery was significantly greater on…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.